Total Pelvic Exenteration for Gynecologic Malignancies

Total pelvic exenteration (PE) is a radical operation, involving en bloc resection of pelvic organs, including reproductive structures, bladder, and rectosigmoid. In gynecologic oncology, it is most commonly indicated for the treatment of advanced primary or locally recurrent cancer. Careful patient...

Full description

Bibliographic Details
Main Authors: Elisabeth J. Diver, J. Alejandro Rauh-Hain, Marcela G. del Carmen
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:International Journal of Surgical Oncology
Online Access:http://dx.doi.org/10.1155/2012/693535
id doaj-29308c24a89647f38081defaa7e6fc7e
record_format Article
spelling doaj-29308c24a89647f38081defaa7e6fc7e2020-11-24T22:01:48ZengHindawi LimitedInternational Journal of Surgical Oncology2090-14022090-14102012-01-01201210.1155/2012/693535693535Total Pelvic Exenteration for Gynecologic MalignanciesElisabeth J. Diver0J. Alejandro Rauh-Hain1Marcela G. del Carmen2Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E Boston, MA 02114, USADivision of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E Boston, MA 02114, USADivision of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Yawkey 9E Boston, MA 02114, USATotal pelvic exenteration (PE) is a radical operation, involving en bloc resection of pelvic organs, including reproductive structures, bladder, and rectosigmoid. In gynecologic oncology, it is most commonly indicated for the treatment of advanced primary or locally recurrent cancer. Careful patient selection and counseling are of paramount importance when considering someone for PE. Part of the evaluation process includes comprehensive assessment to exclude unresectable or metastatic disease. PE can be curative for carefully selected patients with gynecologic cancers. Major complications can be seen in as many as 50% of patients undergoing PE, underscoring the need to carefully discuss risks and benefits of this procedure with patients considering exenterative surgery.http://dx.doi.org/10.1155/2012/693535
collection DOAJ
language English
format Article
sources DOAJ
author Elisabeth J. Diver
J. Alejandro Rauh-Hain
Marcela G. del Carmen
spellingShingle Elisabeth J. Diver
J. Alejandro Rauh-Hain
Marcela G. del Carmen
Total Pelvic Exenteration for Gynecologic Malignancies
International Journal of Surgical Oncology
author_facet Elisabeth J. Diver
J. Alejandro Rauh-Hain
Marcela G. del Carmen
author_sort Elisabeth J. Diver
title Total Pelvic Exenteration for Gynecologic Malignancies
title_short Total Pelvic Exenteration for Gynecologic Malignancies
title_full Total Pelvic Exenteration for Gynecologic Malignancies
title_fullStr Total Pelvic Exenteration for Gynecologic Malignancies
title_full_unstemmed Total Pelvic Exenteration for Gynecologic Malignancies
title_sort total pelvic exenteration for gynecologic malignancies
publisher Hindawi Limited
series International Journal of Surgical Oncology
issn 2090-1402
2090-1410
publishDate 2012-01-01
description Total pelvic exenteration (PE) is a radical operation, involving en bloc resection of pelvic organs, including reproductive structures, bladder, and rectosigmoid. In gynecologic oncology, it is most commonly indicated for the treatment of advanced primary or locally recurrent cancer. Careful patient selection and counseling are of paramount importance when considering someone for PE. Part of the evaluation process includes comprehensive assessment to exclude unresectable or metastatic disease. PE can be curative for carefully selected patients with gynecologic cancers. Major complications can be seen in as many as 50% of patients undergoing PE, underscoring the need to carefully discuss risks and benefits of this procedure with patients considering exenterative surgery.
url http://dx.doi.org/10.1155/2012/693535
work_keys_str_mv AT elisabethjdiver totalpelvicexenterationforgynecologicmalignancies
AT jalejandrorauhhain totalpelvicexenterationforgynecologicmalignancies
AT marcelagdelcarmen totalpelvicexenterationforgynecologicmalignancies
_version_ 1725838445794820096